Cefpodoxime Oral Suspension Shortage
Last Updated: November 19, 2018
Status: Resolved
Products Affected - Description
-
- Cefpodoxime oral suspension, Sandoz, 100 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6169-46
- Cefpodoxime oral suspension, Sun Pharma, 50 mg/5 mL, 100 mL bottle, 1 count, NDC 63304-0965-04
- Cefpodoxime oral suspension, Sun Pharma, 50 mg/5 mL, 50 mL bottle, 1 count, NDC 63304-0965-03
Reason for the Shortage
-
- Aurobindo has discontinued cefpodoxime oral suspension.
- Sandoz has discontinued cefpodoxime oral suspension.
- Sun Pharma has discontinued cefpodoxime oral suspension.
- Northstar only provides product to McKesson customers.
- Rising has product available.
Available Products
-
- Cefpodoxime oral suspension, Northstar LLC, 100 mg/5 mL, 50 mL bottle, 1 count, NDC 16714-0403-01
- Cefpodoxime oral suspension, Northstar LLC, 50 mg/5 mL, 100 mL bottle, 1 count, NDC 16714-0402-02
- Cefpodoxime oral suspension, Northstar LLC, 50 mg/5 mL, 50 mL bottle, 1 count, NDC 16714-0402-01
- Cefpodoxime oral suspension, Rising Pharmaceuticals, 100 mg/5 mL, 100 mL bottle, 1 count, NDC 64980-0403-10
- Cefpodoxime oral suspension, Rising Pharmaceuticals, 100 mg/5 mL, 50 mL bottle, 1 count, NDC 64980-0403-50
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated November 19, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. Created April 6, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.